Skip to main content

XOMA Royalty Corp

XOMADelisted Jul 14, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0000791908

XOMA Royalty Corp was delisted on Jul 14, 2026; its insiders filed their last Form 4 on Jul 16, 2026; 98 institutions reported holding it in 13F filings for Q2 2026, worth $723.7M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding XOMA Royalty Corp changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of XOMA: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders52150−1
Shares6.29M5856.33M+42.2K (+0.7%)
Value$213.8M$20.0K$156.7M−$57.1M (−26.7%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held XOMA Royalty Corp at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to XOMA in Q3 2021
InstitutionSharesValue% of portfolio
Millennium Management LLC9,039$224.0K0.00%
Geneos Wealth Management Inc.1,057$25.0K0.00%
Meridian Wealth Partners, LLC50$1.00K0.00%

Sold out (4)

Institutions that held XOMA Royalty Corp at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of XOMA in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Rhumbline Advisers6,227$212.0K
Brewin Dolphin Ltd350$11.9K
Arkadios Wealth Advisors52$1.00K
Whittier Trust Co1$0

Not filed for Q3 2021 yet (1)

Institutions that held XOMA Royalty Corp at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding XOMA in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
CWM, LLC585$20.0K